Form D Explorer

Source evidence

Ansa Biotechnologies, Inc. · 0001231919-26-001596

D filed Nov. 18, 2026. Extracted source facts are preserved separately from the current issuer profile and normalized display values.

SEC filing indexDownload stored sourceReport a record issue

Explicit source references

These accession references come from the source document. They describe a reported link; they do not establish new financing or an independently verified offering group.

Identity as reported in this document

city
EMERYVILLE
street1
1198 65TH STREET #250
zipCode
94608
entityName
Ansa Biotechnologies, Inc.
entityType
Corporation
stateOrCountry
California
jurisdictionOfInc
DELAWARE
Individual source fields, including raw text and value state
FieldRaw sourceStateParsed valueSource location
Reported finders fees0number0/edgarSubmission/offeringData/salesCommissionsFindersFees/findersFees/dollarAmount
Reported amount sold54403290number54403290/edgarSubmission/offeringData/offeringSalesAmounts/totalAmountSold
Reported sales commissions0number0/edgarSubmission/offeringData/salesCommissionsFindersFees/salesCommissions/dollarAmount
Reported offering amount71903290number71903290/edgarSubmission/offeringData/offeringSalesAmounts/totalOfferingAmount
Reported minimum investment0number0/edgarSubmission/offeringData/minimumInvestmentAccepted
Reported investor count18number18/edgarSubmission/offeringData/investors/totalNumberAlreadyInvested

Document SHA-256: a90b3aa4807960184beb283d5a9bfd9f4916873599df2e8586614074357d2779. This proves extraction identity, not the accuracy of the filer's claims.